Literature DB >> 23110532

Drug discovery applications for KNIME: an open source data mining platform.

Michael P Mazanetz1, Robert J Marmon, Catherine B T Reisser, Inaki Morao.   

Abstract

Technological advances in high-throughput screening methods, combinatorial chemistry and the design of virtual libraries have evolved in the pursuit of challenging drug targets. Over the last two decades a vast amount of data has been generated within these fields and as a consequence data mining methods have been developed to extract key pieces of information from these large data pools. Much of this data is now available in the public domain. This has been helpful in the arena of drug discovery for both academic groups and for small to medium sized enterprises which previously would not have had access to such data resources. Commercial data mining software is sometimes prohibitively expensive and the alternate open source data mining software is gaining momentum in both academia and in industrial applications as the costs of research and development continue to rise. KNIME, the Konstanz Information Miner, has emerged as a leader in open source data mining tools. KNIME provides an integrated solution for the data mining requirements across the drug discovery pipeline through a visual assembly of data workflows drawing from an extensive repository of tools. This review will examine KNIME as an open source data mining tool and its applications in drug discovery.

Mesh:

Year:  2012        PMID: 23110532     DOI: 10.2174/156802612804910331

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  32 in total

1.  Exploring Protein-Protein Interactions as Drug Targets for Anti-cancer Therapy with In Silico Workflows.

Authors:  Alexander Goncearenco; Minghui Li; Franco L Simonetti; Benjamin A Shoemaker; Anna R Panchenko
Journal:  Methods Mol Biol       Date:  2017

2.  Pred-hERG: A Novel web-Accessible Computational Tool for Predicting Cardiac Toxicity.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Luciano M Lião; Alexander Tropsha; Carolina H Andrade
Journal:  Mol Inform       Date:  2015-07-20       Impact factor: 3.353

3.  Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.

Authors:  Howard I Scher; Ryon P Graf; Nicole A Schreiber; Brigit McLaughlin; David Lu; Jessica Louw; Daniel C Danila; Lyndsey Dugan; Ann Johnson; Glenn Heller; Martin Fleisher; Ryan Dittamore
Journal:  Eur Urol       Date:  2016-12-12       Impact factor: 20.096

4.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

5.  Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods.

Authors:  Rachel L Richesson; Jimeng Sun; Jyotishman Pathak; Abel N Kho; Joshua C Denny
Journal:  Artif Intell Med       Date:  2016-06-25       Impact factor: 5.326

6.  Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Front Pharmacol       Date:  2015-05-13       Impact factor: 5.810

Review 7.  How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.

Authors:  Douglas B Kell; Stephen G Oliver
Journal:  Front Pharmacol       Date:  2014-10-31       Impact factor: 5.810

8.  A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs.

Authors:  Steve O Hagan; Neil Swainston; Julia Handl; Douglas B Kell
Journal:  Metabolomics       Date:  2014-09-19       Impact factor: 4.290

9.  MetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous Metabolites.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Front Pharmacol       Date:  2016-08-22       Impact factor: 5.810

10.  A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis.

Authors:  Noureddine Ben Khalaf; Susie Pham; Giuseppe Romeo; Sara Abdelghany; Sebastiano Intagliata; Peter Sedillo; Loredana Salerno; Jessica Gonzales; Dahmani M Fathallah; Douglas J Perkins; Ivy Hurwitz; Valeria Pittalà
Journal:  J Comput Aided Mol Des       Date:  2021-02-22       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.